Genezen and Atsena form strategic manufacturing partnership in Jan 2026. Genezen is a gene therapy CDMO, Atsena is a clinical gene therapy company.
On January 20, 2026, Genezen, a top gene therapy Contract Development and Manufacturing Organization (CDMO) based in Lexington, Massachusetts, and Atsena Therapeutics, a clinical-stage gene therapy company from Durham, North Carolina, announced a collaboration. Atsena Therapeutics aims to harness the transformative potential of genetic treatments. The partnership allows Genezen to provide its expertise in gene therapy manufacturing to support Atsena Therapeutics. This collaboration signifies a significant step forward in advancing gene therapy research and development efforts.
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments